The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer: Suppression of Tumorigenic Property of Lung Cancer Cells and Their Sensitization to Doxorubicin-Induced Apoptosis by miR-1
Open accessAbstract
Micro-RNAs are approximately 21-25-nucleotide-long noncoding RNAs that regulate gene expression primarily at the post-transcriptional level in animals. Here, we report that micro-RNA-1 (miR-1), abundant in the cardiac and smooth muscles, is expressed in the lung and is down-regulated in human primary lung cancer tissues and cell lines. In situ hybridization demonstrated localization of miR-1 in bronchial epithelial cells. The tumor suppressor C/EBPalpha, frequently suppressed in lung cancer, reactivated miR-1 expression in the lung cancer cells. Repressed miR-1 was also activated in lung cancer cells upon treatment with a histone deacetylase inhibitor. These observations led us to examine the antitumorigenic potential of miR-1 in lung cancer cells. Expression of miR-1 in nonexpressing A549 and H1299 cells reversed their tumorigenic properties, such as growth, replication potential, motility/migration, clonogenic survival, and tumor formation in nude mice. Exogenous miR-1 significantly reduced expression of oncogenic targets, such as MET, a receptor tyrosine kinase, and Pim-1, a Ser/Thr kinase, frequently up-regulated in lung cancer. Similarly, the levels of two additional targets, FoxP1, a transcription factor with oncogeneic property, and HDAC4 that represses differentiation-promoting genes, were reduced in miR-1-expressing cells. Conversely, depletion of miR-1 facilitated N417 cell growth with concomitant elevation of these targets. Further, ectopic miR-1 induced apoptosis in A549 cells in response to the potent anticancer drug doxorubicin. Enhanced activation of caspases 3 and 7, cleavage of their substrate PARP-1, and depletion of anti-apoptotic Mcl-1 contributed to the sensitivity of miR-1-expressing cells to doxorubicin. Thus, miR-1 has potential therapeutic application against lung cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
RETRACTED: Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas
Kutay, H., Bai, S., Datta, J., Motiwala, T., Pogribny, I., Frankel, W., Jacob, S. T., & Ghoshal, K. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20982 · Cited by 608
Self-citationRetractedDatta, J., Kutay, H., Nasser, M. W., Nuovo, G. J., Wang, B., Majumder, S., Liu, C.-G., Volinia, S., Croce, C. M., Schmittgen, T. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6655 · Cited by 438
Self-citationRetractedGhoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 431
Self-citationRetractedThe Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding
Martin, M. M., Buckenberger, J. A., Jiang, J., Malana, G. E., Nuovo, G. J., Chotani, M., Feldman, D. S., Schmittgen, T. D., & Elton, T. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701050200 · Cited by 259
Self-citationRetractedMotiwala, T., Kutay, H., Ghoshal, K., Bai, S., Seimiya, H., Tsuruo, T., Suster, S. M., Morrison, C., & Jacob, S. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405451101 · Cited by 111
Self-citationRetractedLewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & Steitz, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,822
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J.-F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2006) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,779
MicroRNA biogenesis: coordinated cropping and dicing
Kim, V. N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1644 · Cited by 2,546
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,354
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
Zhao, Y., Samal, E., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03817 · Cited by 1,557
van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., Richardson, J. A., & Olson, E. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608791103 · Cited by 1,507
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R., & Jacks, T. (2007) · Nature Genetics · doi:10.1038/ng2003 · Cited by 1,463
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
MicroRNAs in cell proliferation, cell death, and tumorigenesis
Hwang, H.-W., & Mendell, J. T. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603023 · Cited by 1,399
Small non-coding RNAs in animal development
Stefani, G., & Slack, F. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2347 · Cited by 1,368
Current Protocols in Bioinformatics
(2002) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471250953 · Cited by 1,207
MicroRNA-Cancer Connection: The Beginning of a New Tale
Calin, G. A., & Croce, C. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0800 · Cited by 1,053
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Peltier, H. J., & Latham, G. J. (2008) · RNA · doi:10.1261/rna.939908 · Cited by 820
Mechanisms of microRNA-mediated gene regulation in animal cells
Nilsen, T. W. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.02.011 · Cited by 574
MicroRNAs and their regulatory roles in animals and plants
Zhang, B., Wang, Q., & Pan, X. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20869 · Cited by 556
Structural insights into the degradation of Mcl-1 induced by BH3 domains
Czabotar, P. E., Lee, E. F., van Delft, M. F., Day, C. L., Smith, B. J., Huang, D. C. S., Fairlie, W. D., Hinds, M. G., & Colman, P. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701297104 · Cited by 446
microRNAs in Vertebrate Physiology and Human Disease
Chang, T.-C., & Mendell, J. T. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092351 · Cited by 431
Sokol, N. S., & Ambros, V. (2005) · Genes & Development · doi:10.1101/gad.1356105 · Cited by 400
Kaposi-Novak, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27236 · Cited by 398
MicroRNAs as Potential Agents to Alter Resistance to Cytotoxic Anticancer Therapy
Weidhaas, J. B., Babar, I., Nallur, S. M., Trang, P., Roush, S., Boehm, M., Gillespie, E., & Slack, F. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2858 · Cited by 387
MicroRNAs and Immunity: Tiny Players in a Big Field
Taganov, K. D., Boldin, M. P., & Baltimore, D. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.005 · Cited by 343
Foxp1 is an essential transcriptional regulator of B cell development
Hu, H., Wang, B., Borde, M., Nardone, J., Maika, S., Allred, L., Tucker, P. W., & Rao, A. (2006) · Nature Immunology · doi:10.1038/ni1358 · Cited by 328
Self-citationThe Guardian's Little Helper: MicroRNAs in the p53 Tumor Suppressor Network
He, X., He, L., & Hannon, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2672 · Cited by 317
Molecular Genetics of Lung Cancer
Sekido, Y., Fong, K. M., & Minna, J. D. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152202 · Cited by 313
Using TESS to Predict Transcription Factor Binding Sites in DNA Sequence
Schug, J. (2008) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0206s21 · Cited by 301
Morishita, D., Katayama, R., Sekimizu, K., Tsuruo, T., & Fujita, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0634 · Cited by 292
Targeting Apoptosis Pathways in Cancer Therapy
Fulda, S., & Debatin, K.-M. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332763 · Cited by 290
MicroRNAs and chromosomal abnormalities in cancer cells
Calin, G. A., & Croce, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209910 · Cited by 263
Song, L., Coppola, D., Livingston, S., Cress, W. D., & Haura, E. B. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.3.1496 · Cited by 215
The evolution of animal microRNA function
Niwa, R., & Slack, F. J. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.02.004 · Cited by 208
MicroRNA function in neuronal development, plasticity and disease
Fiore, R., Siegel, G., & Schratt, G. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.12.006 · Cited by 199
Ramalingam, S. S., Parise, R. A., Ramananthan, R. K., Lagattuta, T. F., Musguire, L. A., Stoller, R. G., Potter, D. M., Argiris, A. E., Zwiebel, J. A., Egorin, M. J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0162 · Cited by 193
Banham, A. H., Connors, J. M., Brown, P. J., Cordell, J. L., Ott, G., Sreenivasan, G., Farinha, P., Horsman, D. E., & Gascoyne, R. D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1065.11.3 · Cited by 184
Interrelated Roles for Mcl-1 and BIM in Regulation of TRAIL-mediated Mitochondrial Apoptosis
Han, J., Goldstein, L. A., Gastman, B. R., & Rabinowich, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510349200 · Cited by 182
Stress-induced Reversal of MicroRNA Repression and mRNA P-body Localization in Human Cells
BHATTACHARYYA, S. N., HABERMACHER, R., MARTINE, U., CLOSS, E. I., & FILIPOWICZ, W. (2006) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2006.71.038 · Cited by 170
FOXP1: a potential therapeutic target in cancer
Koon, H. B., Ippolito, G. C., Banham, A. H., & Tucker, P. W. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.7.955 · Cited by 170
MicroRNA genes are frequently located near mouse cancer susceptibility loci
Sevignani, C., Calin, G. A., Nnadi, S. C., Shimizu, M., Davuluri, R. V., Hyslop, T., Démant, P., Croce, C. M., & Siracusa, L. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702177104 · Cited by 154
Takimoto, C. H. M., & Awada, A. H. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0639-9 · Cited by 152
RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS
Mishima, T., Mizuguchi, Y., Kawahigashi, Y., Takizawa, T., & Takizawa, T. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.035 · Cited by 142
Nuovo, G. (2008) · Methods · doi:10.1016/j.ymeth.2007.10.008 · Cited by 135
Self-citationThe Met pathway: master switch and drug target in cancer progression
Mazzone, M., & Comoglio, P. M. (2006) · The FASEB Journal · doi:10.1096/fj.06-5947rev · Cited by 120
Epigenetic Modulation of Tumor Suppressor CCAAT/Enhancer Binding Protein α Activity in Lung Cancer
Tada, Y., Brena, R. M., Hackanson, B. W., Morrison, C., Otterson, G. A., & Plass, C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj093 · Cited by 115
C/EBP transcription factors in the lung epithelium
Cassel, T. N., & Nord, M. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00023.2003 · Cited by 103
C/EBPα: A tumour suppressor in multiple tissues?
Schuster, M. B., & Porse, B. T. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.003 · Cited by 99
Hogan, C., Hutchison, C., Marcar, L., Milne, D., Saville, M. K., Goodlad, J. R., Kernohan, N., & Meek, D. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709695200 · Cited by 87
State of the Art in Therapy for Non-Small Cell Lung Cancer
Laskin, J. J., & Sandler, A. B. (2005) · Cancer Investigation · doi:10.1081/cnv-200067172 · Cited by 64
Adiseshaiah, P. P., Lindner, D. J., Kalvakolanu, D. V., & Reddy, S. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4687 · Cited by 63
microRNAs put their signatures on the heart
van Rooij, E., & Olson, E. N. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00206.2007 · Cited by 55
C/EBPα mutations in lung cancer
Costa, D. B., Dayaram, T., D’Alò, F., Wouters, B. J., Tenen, D. G., Meyerson, M. M., Tsao, M., & Halmos, B. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.04.011 · Cited by 17
Cited by
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798
The role of let-7 in cell differentiation and cancer
Boyerinas, B., Park, S.-M., Hau, A., Murmann, A. E., & Peter, M. E. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0184 · Cited by 669
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
For better or for worse: the role of Pim oncogenes in tumorigenesis
Nawijn, M. C., Alendar, A., & Berns, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2986 · Cited by 481
Metadata
- Authors
- Nasser, M. W., Datta, J., Nuovo, G., Kutay, H., Motiwala, T., Majumder, S., Wang, B., Suster, S., Jacob, S. T., & Ghoshal, K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 283
- Issue
- 48
- Pages
- 33394-33406
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2042907812
- Cited by
- 360
- References
- 66
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.